...
首页> 外文期刊>EMBO Journal >IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production
【24h】

IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production

机译:IRAK-M介导toll样受体/ IL-1R-inducedNFκB细胞因子激活和生产

获取原文
获取原文并翻译 | 示例
           

摘要

Toll-like receptors transduce their signals through the adaptor molecule MyD88 and members of the IL-1R-associated kinase family (IRAK-1, 2, M and 4). IRAK-1 and IRAK-2, known to form Myddosomes with MyD88-IRAK-4, mediate TLR7-induced TAK1-dependent NFκB activation. IRAK-M was previously known to function as a negative regulator that prevents the dissociation of IRAKs from MyD88, thereby inhibiting downstream signalling. However, we now found that IRAK-M was also able to interact with MyD88-IRAK-4 to form IRAK-M Myddosome to mediate TLR7-induced MEKK3-dependent second wave NFκB activation, which is uncoupled from post-transcriptional regulation. As a result, the IRAK-M-dependent pathway only induced expression of genes that are not regulated at the post-transcriptional levels (including inhibitory molecules SOCS1, SHIP1, A20 and IκBα), exerting an overall inhibitory effect on inflammatory response. On the other hand, through interaction with IRAK-2, IRAK-M inhibited TLR7-mediated production of cytokines and chemokines at translational levels. Taken together, IRAK-M mediates TLR7-induced MEKK3-dependent second wave NFκB activation to produce inhibitory molecules as a negative feedback for the pathway, while exerting inhibitory effect on translational control of cytokines and chemokines.
机译:toll样受体信号转导通过衔接分子MyD88和成员IL-1R-associated激酶家族(IRAK-1 2米和4)。IRAK-1和IRAK-2形成Myddosomes MyD88-IRAK-4,调解TLR7-induced TAK1-dependent NFκB激活。IRAK-M以前作为一个已知函数消极监管机构阻止了分裂伊拉克共和国的MyD88,从而抑制下游信号。IRAK-M也能够相互作用MyD88-IRAK-4形成IRAK-M Myddosome调解TLR7-induced MEKK3-dependent第二波NFκB激活,分道扬镳转录后调控。只IRAK-M-dependent通路诱导表达的基因是不规范转录后水平(包括抑制分子SOCS1, SHIP1, A20κBα),施加一个整体对炎症的抑制作用响应。IRAK-2 IRAK-M抑制TLR7-mediated细胞因子和趋化因子的生产转化水平。介导TLR7-induced MEKK3-dependent第二波NFκB激活产生抑制分子作为一个负面的反馈途径,发挥抑制作用转化细胞因子和趋化因子的控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号